Magda D - Search Results

1

Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.

Miller RA, Woodburn KW, Fan Q, Lee I, Miles D, Duran G, Sikic B, Magda D. Miller RA, et al. Among authors: magda d. Clin Cancer Res. 2001 Oct;7(10):3215-21. Clin Cancer Res. 2001. PMID: 11595717

2

Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines.

Magda D, Lecane P, Miller RA, Lepp C, Miles D, Mesfin M, Biaglow JE, Ho VV, Chawannakul D, Nagpal S, Karaman MW, Hacia JG. Magda D, et al. Cancer Res. 2005 May 1;65(9):3837-45. doi: 10.1158/0008-5472.CAN-04-4099. Cancer Res. 2005. PMID: 15867382

3

Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines.

Lecane PS, Karaman MW, Sirisawad M, Naumovski L, Miller RA, Hacia JG, Magda D. Lecane PS, et al. Among authors: magda d. Cancer Res. 2005 Dec 15;65(24):11676-88. doi: 10.1158/0008-5472.CAN-05-2754. Cancer Res. 2005. PMID: 16357179

4

Motexafin gadolinium: a novel redox active drug for cancer therapy.

Magda D, Miller RA. Magda D, et al. Semin Cancer Biol. 2006 Dec;16(6):466-76. doi: 10.1016/j.semcancer.2006.09.002. Epub 2006 Sep 26. Semin Cancer Biol. 2006. PMID: 17112739 Review.

5

Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species.

Magda D, Lepp C, Gerasimchuk N, Lee I, Sessler JL, Lin A, Biaglow JE, Miller RA. Magda D, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1025-36. doi: 10.1016/s0360-3016(01)01810-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704327

6

Motexafin gadolinium reacts with ascorbate to produce reactive oxygen species.

Magda D, Gerasimchuk N, Lecane P, Miller RA, Biaglow JE, Sessler JL. Magda D, et al. Chem Commun (Camb). 2002 Nov 21;(22):2730-1. doi: 10.1039/b208760j. Chem Commun (Camb). 2002. PMID: 12510321

7

Phototherapy of cancer and atheromatous plaque with texaphyrins.

Woodburn KW, Fan Q, Kessel D, Wright M, Mody TD, Hemmi G, Magda D, Sessler JL, Dow WC, Miller RA, Young SW. Woodburn KW, et al. Among authors: magda d. J Clin Laser Med Surg. 1996 Oct;14(5):343-8. doi: 10.1089/clm.1996.14.343. J Clin Laser Med Surg. 1996. PMID: 9612202

8

Tumor localization and antitumor efficacy of novel sapphyrin compounds.

Naumovski L, Sirisawad M, Lecane P, Chen J, Ramos J, Wang Z, Cortez C, Magda D, Thiemann P, Boswell G, Miles D, Cho DG, Sessler JL, Miller R. Naumovski L, et al. Among authors: magda d. Mol Cancer Ther. 2006 Nov;5(11):2798-805. doi: 10.1158/1535-7163.MCT-06-0246. Mol Cancer Ther. 2006. PMID: 17121926

9

Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression.

Wang Z, Lecane PS, Thiemann P, Fan Q, Cortez C, Ma X, Tonev D, Miles D, Naumovski L, Miller RA, Magda D, Cho DG, Sessler JL, Pike BL, Yeligar SM, Karaman MW, Hacia JG. Wang Z, et al. Among authors: magda d. Mol Cancer. 2007 Jan 19;6:9. doi: 10.1186/1476-4598-6-9. Mol Cancer. 2007. PMID: 17233922 Free PMC article.

10

Motexafin gadolinium (Gd-Tex) selectively induces apoptosis in HIV-1 infected CD4+ T helper cells.

Perez OD, Nolan GP, Magda D, Miller RA, Herzenberg LA, Herzenberg LA. Perez OD, et al. Among authors: magda d. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2270-4. doi: 10.1073/pnas.261711499. Proc Natl Acad Sci U S A. 2002. PMID: 11854523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters